Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Boelens JJ"" wg kryterium: Autor


Tytuł :
Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing.
Autorzy :
Bartelink IH
Boelens JJ
Bredius RG
Egberts AC
Wang C
Bierings MB
Shaw PJ
Nath CE
Hempel G
Zwaveling J
Danhof M
Knibbe CA
Bartelink, Imke H
Boelens, Jaap J
Bredius, Robbert G M
Egberts, Antoine C G
Wang, Chenguang
Bierings, Marc B
Shaw, Peter J
Nath, Christa E
Pokaż więcej
Źródło :
Clinical Pharmacokinetics; 2012, Vol. 51 Issue 5, p331-345, 15p
Czasopismo naukowe
Tytuł :
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Autorzy :
Corbacioglu S ()
Cesaro S ()
Faraci M ()
Valteau-Couanet D ()
Gruhn B ()
Rovelli A ()
Boelens JJ ()
Hewitt A ()
Schrum J ()
Schulz AS ()
Müller I ()
Stein J ()
Wynn R ()
Greil J ()
Sykora KW ()
Matthes-Martin S ()
Führer M ()
O'Meara A ()
Toporski J ()
Sedlacek P ()
Pokaż więcej
Źródło :
Lancet. 4/7/2012, Vol. 379 Issue 9823, p1301-1309. 9p.
Czasopismo naukowe
Tytuł :
Correction: Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens.
Autorzy :
Versluys AB; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. .
Boelens JJ; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, Memorial Sloan Kettering, New York, NY, USA.
Pronk C; Department of Pediatric Oncology and Hematology, Skane University Hospital, Lund, Sweden.
Lankester A; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
Bordon V; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Ifversen M; Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Jackmann N; Department of Women's and Children's Health, University Children's Hospital, Uppsala, Sweden.
Sundin M; Pediatric Hematology, Immunology and HCT, Astrid Lindgren Children's Hospital, University Hospital; and Division of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Vettenranta K; University of Helsinki and Children's Hospital, University of Helsinki, Helsinki, Finland.
Abrahamsson J; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Mellgren K; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1485.
Typ publikacji :
Published Erratum
Tytuł :
Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens.
Autorzy :
Versluys AB; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. .
Boelens JJ; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, Memorial Sloan Kettering, New York, NY, USA.
Pronk C; Department of Pediatric Oncology and Hematology, Skane University Hospital, Lund, Sweden.
Lankester A; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
Bordon V; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Ifversen M; Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Jackmann N; Department of Women's and Children's Health, University Children's Hospital, Uppsala, Sweden.
Sundin M; Pediatric Hematology, Immunology and HCT, Astrid Lindgren Children's Hospital, Karolinska University Hospital; and Division of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Vettenranta K; University of Helsinki and Children´s Hospital, University of Helsinki, Helsinki, Finland.
Abrahamsson J; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Mellgren K; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1426-1432. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pre-Transplantation Variables and Correlation with Post-Transplant Outcomes.
Autorzy :
Llaurador G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave. New York, NY 10065; Department of Pediatrics, Weill Cornell Medical College, 525 E 68th St, New York, NY 10065.
Nicoletti E; Rocket Pharmaceuticals, Inc. 9 Cedarbrook Drive, Cranbury, NJ 08512.
Prockop SE; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave. New York, NY 10065; Department of Pediatrics, Weill Cornell Medical College, 525 E 68th St, New York, NY 10065.
Hsu S; Histocompatibility/Molecular Genetics Laboratory, American Red Cross Penn Jersey Region 700 Spring Garden Street. Philadelphia, PA 19123.
Fuller K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave. New York, NY 10065.
Mauguen A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Ave. New York, NY.
O'Reilly G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave. New York, NY 10065.
Boelens JJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave. New York, NY 10065.
Boulad F; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave. New York, NY 10065. Electronic address: .
Pokaż więcej
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2021 May 31. Date of Electronic Publication: 2021 May 31.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma.
Autorzy :
Szanto CL; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Tamminga SM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Delemarre EM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
de Koning CCH; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
van den Beemt DAMH; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Dunnebach E; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Tas ML; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.
Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.
Tytgat LGAM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.
van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Division Imaging and Cancer, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Kraal KCJM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.
Boelens JJ; Stem Cell Transplantation and Cellular Therapies Program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2021 Apr 26; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Minimal Parameter Set Facilitating Early Decision-making in the Diagnosis of Hemophagocytic Lymphohistiocytosis.
Autorzy :
Smits BM; Center of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.; Department of Pediatric Immunology and Infectious Diseases, UMC Utrecht, Utrecht, The Netherlands.
van Montfrans J; Department of Pediatric Immunology and Infectious Diseases, UMC Utrecht, Utrecht, The Netherlands.
Merrill SA; Division of Hematology/Oncology, West Virginia University, Morgantown, WV, USA.
van de Corput L; Center of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
van Gijn M; Center of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
de Vries A; Department of Pediatric Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
van den Bos C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Abbink F; Department of Pediatric Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
van der Molen RG; Department of Laboratory Medicine, Laboratory for Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Dors N; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Lindemans C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Boelens JJ; Center of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nierkens S; Center of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. .; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. .
Pokaż więcej
Źródło :
Journal of clinical immunology [J Clin Immunol] 2021 Mar 29. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.
Autorzy :
Zinter MS; Division of Critical Care Medicine and.; Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, School of Medicine, University of California, San Francisco, CA.
Lindemans CA; Department of Pediatric Stem Cell Transplantation, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Hematopoietic Cell Transplantation, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Versluys BA; Department of Pediatric Stem Cell Transplantation, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Hematopoietic Cell Transplantation, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Mayday MY; Graduate Program in Experimental Pathology, and Yale Stem Cell Center, Department of Pathology, Yale University, New Haven, CT.
Sunshine S; Department of Biochemistry and Biophysics, School of Medicine.
Reyes G; Division of Critical Care Medicine and.
Sirota M; Bakar Computational Health Sciences Institute, and.; Department of Pediatrics, School of Medicine, University of California, San Francisco, CA.
Sapru A; Division of Critical Care Medicine, Department of Pediatrics, School of Medicine, University of California, Los Angeles, CA.
Matthay MA; Department of Medicine and.; Department of Anesthesiology, Cardiovascular Research Institute, School of Medicine, University of California, San Francisco, CA.
Kharbanda S; Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, School of Medicine, University of California, San Francisco, CA.
Dvorak CC; Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, School of Medicine, University of California, San Francisco, CA.
Boelens JJ; Department of Pediatric Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, NY; and.
DeRisi JL; Department of Biochemistry and Biophysics, School of Medicine.; Chan Zuckerberg Biohub, San Francisco, CA.
Pokaż więcej
Źródło :
Blood [Blood] 2021 Mar 25; Vol. 137 (12), pp. 1679-1689.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies